Joseph D. Wilkins Jr. - May 27, 2022 Form 4 Insider Report for QUIDEL CORP /DE/ (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Joseph D. Wilkins, Jr.
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:22 PM
Previous filing
May 20, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -1.91K -100% 0 May 27, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Joseph D. Wilkins Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.